טוען...
To add or not to add a new treatment arm to a multiarm study: A decision‐theoretic framework
Multiarm clinical trials, which compare several experimental treatments against control, are frequently recommended due to their efficiency gain. In practise, all potential treatments may not be ready to be tested in a phase II/III trial at the same time. It has become appealing to allow new treatme...
שמור ב:
| הוצא לאור ב: | Stat Med |
|---|---|
| Main Authors: | , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
John Wiley and Sons Inc.
2019
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6619445/ https://ncbi.nlm.nih.gov/pubmed/31115078 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/sim.8194 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|